{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:47:47Z","timestamp":1790801267705,"version":"4.1.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP23K07706"],"award-info":[{"award-number":["JP23K07706"]}]},{"name":"JSPS KAKENHI","award":["JP23K07706"],"award-info":[{"award-number":["JP23K07706"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Our study revealed that high mobility group box 1 activates the mineralocorticoid receptor (MR) through the receptor for advanced glycation end products (RAGE) in AKI.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>MR antagonists and RAGE aptamers inhibited high mobility group box 1\u2013induced Rac1\/MR activation and downstream inflammatory molecules in endothelial cells.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>MR antagonists and RAGE aptamers may represent promising therapeutic strategies for preventing AKI and CKD progression.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although AKI is associated with an increased risk of CKD, the underlying mechanisms remain unclear. High mobility group box 1 (HMGB1), one of the ligands for the receptor for advanced glycation end products (RAGE), is elevated in patients with AKI. We recently demonstrated that the mineralocorticoid receptor (MR) is activated by the RAGE\/Rac1 pathway, contributing to chronic renal damage in hypertensive mice. Therefore, this study investigated the role of the HMGB1\/RAGE\/MR pathway in AKI and progression to CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a mouse model of renal ischemia\u2013reperfusion (I\/R) with or without MR antagonist (MRA).\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      experiments were conducted using cultured endothelial cells to examine the interaction between the HMGB1\/RAGE and Rac1\/MR pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In renal I\/R injury mice, renal MR activation was associated with elevated serum HMGB1, renal RAGE, and activated Rac1, all of which were suppressed by MRA. Renal I\/R injury led to renal dysfunction, tubulointerstitial injury, and increased expressions of inflammation and fibrosis mediators, which were ameliorated by MRA.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      , RAGE aptamer or MRA inhibited HMGB1-induced Rac1\/MR activation and upregulation of monocyte chemoattractant protein 1 and NF-\u03baB expressions. Seven days after I\/R injury, renal I\/R injury mice developed CKD, whereas MRA prevented renal injury progression and decreased the mortality rate. Furthermore, in case of MRA treatment even after I\/R injury, attenuated renal dysfunction compared with untreated mice was also observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that HMGB1 may play a crucial role in AKI and CKD development by activating the Rac1\/MR pathway through interactions with RAGE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000665","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:05:45Z","timestamp":1733400345000},"page":"208-218","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Involvement of Mineralocorticoid Receptor Activation by High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Development of Acute Kidney Injury"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3015-3748","authenticated-orcid":false,"given":"Tomoyuki","family":"Otsuka","sequence":"first","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"},{"name":"Division of Kidney Health and Aging, The Center for Integrated Kidney Research and Advance, Shimane University Faculty of Medicine, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-8711","authenticated-orcid":false,"given":"Hajime","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"},{"name":"Division of Kidney Health and Aging, The Center for Integrated Kidney Research and Advance, Shimane University Faculty of Medicine, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Okuma","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"},{"name":"Division of Kidney Health and Aging, The Center for Integrated Kidney Research and Advance, Shimane University Faculty of Medicine, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-0465","authenticated-orcid":false,"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-269X","authenticated-orcid":false,"given":"Maki","family":"Murakoshi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Nakata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-4433","authenticated-orcid":false,"given":"Tomohito","family":"Gohda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-7571","authenticated-orcid":false,"given":"Takanori","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Biotechnology, Fukui Prefectural University, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-8598","authenticated-orcid":false,"given":"Yuichiro","family":"Higashimoto","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Kurume University School of Medicine, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-9747","authenticated-orcid":false,"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"9","key":"B1-20250227","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"World incidence of AKI: a meta-analysis","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B2-20250227","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","article-title":"Spectrum of acute renal failure in the intensive care unit: the Picard experience","volume":"66","author":"Mehta","year":"2004","journal-title":"Kidney Int."},{"issue":"1","key":"B3-20250227","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","article-title":"Acute kidney injury","volume":"7","author":"Kellum","year":"2021","journal-title":"Nat Rev Dis Primers."},{"issue":"6","key":"B4-20250227","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2010050484","article-title":"Sepsis and acute kidney injury","volume":"22","author":"Zarjou","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B5-20250227","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ackd.2016.01.014","article-title":"Delayed consequences of acute kidney injury","volume":"23","author":"Parr","year":"2016","journal-title":"Adv Chronic Kidney Dis."},{"issue":"3","key":"B6-20250227","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.04961107","article-title":"Epidemiology of acute kidney injury","volume":"3","author":"Cerd\u00e1","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B7-20250227","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"issue":"2","key":"B8-20250227","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tcb.2006.12.001","article-title":"HMG chromosomal proteins in development and disease","volume":"17","author":"Hock","year":"2007","journal-title":"Trends Cell Biol."},{"issue":"6894","key":"B9-20250227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature."},{"issue":"11","key":"B10-20250227","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2009101048","article-title":"HMGB1 contributes to kidney ischemia reperfusion injury","volume":"21","author":"Wu","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B11-20250227","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.hrtlng.2021.07.010","article-title":"Correlation of blood high mobility group box-1 protein with mortality of patients with sepsis: a meta-analysis","volume":"50","author":"Cai","year":"2021","journal-title":"Heart Lung."},{"issue":"3-4","key":"B12-20250227","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2119\/2007-00107.Bruchfeld","article-title":"High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)","volume":"14","author":"Bruchfeld","year":"2008","journal-title":"Mol Med."},{"issue":"3","key":"B13-20250227","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.apsb.2016.02.004","article-title":"The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharm Sin B."},{"key":"B14-20250227","doi-asserted-by":"crossref","first-page":"109005","DOI":"10.1016\/j.biopha.2019.109005","article-title":"HMGB1\/RAGE pro-inflammatory axis promotes vascular endothelial cell apoptosis in limb ischemia\/reperfusion injury","volume":"116","author":"Mi","year":"2019","journal-title":"Biomed Pharmacother."},{"issue":"4","key":"B15-20250227","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/bies.20558","article-title":"GTP-binding proteins of the Rho\/Rac family: regulation, effectors and functions in vivo","volume":"29","author":"Bustelo","year":"2007","journal-title":"Bioessays."},{"issue":"2","key":"B16-20250227","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension."},{"issue":"9","key":"B17-20250227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2010.265","article-title":"Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase","volume":"78","author":"Fujii","year":"2010","journal-title":"Kidney Int."},{"issue":"8","key":"B18-20250227","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway","volume":"121","author":"Shibata","year":"2011","journal-title":"J Clin Invest."},{"issue":"1","key":"B19-20250227","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000445080","article-title":"Mineralocorticoid receptor antagonism: a promising therapeutic approach to treat ischemic AKI","volume":"134","author":"Barrera-Chimal","year":"2016","journal-title":"Nephron."},{"issue":"1","key":"B20-20250227","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2012.352","article-title":"Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury","volume":"83","author":"Barrera-Chimal","year":"2013","journal-title":"Kidney Int."},{"issue":"1","key":"B21-20250227","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41598-018-21176-5","article-title":"RAGE-aptamer attenuates deoxycorticosterone acetate\/salt-induced renal injury in mice","volume":"8","author":"Taguchi","year":"2018","journal-title":"Sci Rep."},{"issue":"5","key":"B22-20250227","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00130.2004","article-title":"Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice","volume":"288","author":"Wang","year":"2005","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B23-20250227","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ki.2013.398","article-title":"Asymmetric dimethylarginine accumulates in the kidney during ischemia\/reperfusion injury","volume":"85","author":"Nakayama","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"B24-20250227","doi-asserted-by":"crossref","first-page":"F1735","DOI":"10.1152\/ajprenal.90427.2008","article-title":"Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress","volume":"295","author":"Hagiwara","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"B25-20250227","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mvr.2013.08.010","article-title":"Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells","volume":"90","author":"Higashimoto","year":"2013","journal-title":"Microvasc Res."},{"issue":"6","key":"B26-20250227","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/db16-1281","article-title":"RAGE-aptamer blocks the development and progression of experimental diabetic nephropathy","volume":"66","author":"Matsui","year":"2017","journal-title":"Diabetes."},{"key":"B27-20250227","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2119\/molmed.2017.00099","article-title":"RAGE-aptamer attenuates the growth and liver metastasis of malignant melanoma in nude mice","volume":"23","author":"Nakamura","year":"2017","journal-title":"Mol Med."},{"issue":"11","key":"B28-20250227","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.febslet.2006.04.050","article-title":"Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation","volume":"580","author":"Yoshida","year":"2006","journal-title":"FEBS Lett."},{"issue":"1","key":"B29-20250227","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41598-020-80940-8","article-title":"Differential organ-specific inflammatory response to progranulin in high-fat diet-fed mice","volume":"11","author":"Murakoshi","year":"2021","journal-title":"Sci Rep."},{"issue":"8","key":"B30-20250227","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1681\/ASN.2010020218","article-title":"NF-kappaB in renal inflammation","volume":"21","author":"Sanz","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B31-20250227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.2015030234","article-title":"Renal hemodynamics in AKI: in search of new treatment targets","volume":"27","author":"Matejovic","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B32-20250227","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2014.04.026","article-title":"The effect of physical activity or exercise on key biomarkers in atherosclerosis\u2014a systematic review","volume":"235","author":"Palmefors","year":"2014","journal-title":"Atherosclerosis."},{"issue":"2","key":"B33-20250227","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cphy.c110041","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Compr Physiol."},{"issue":"6","key":"B34-20250227","doi-asserted-by":"crossref","first-page":"F873","DOI":"10.1152\/ajprenal.00092.2012","article-title":"HMGB1 in renal ischemic injury","volume":"303","author":"Rabadi","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"issue":"4","key":"B35-20250227","first-page":"820","article-title":"Mineralocorticoid receptor antagonism ameliorates podocyte injury and proteinuria in diabetic nephropathy","volume":"25","author":"Tai","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B36-20250227","doi-asserted-by":"crossref","first-page":"F78","DOI":"10.1152\/ajprenal.00077.2007","article-title":"Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone","volume":"293","author":"Mej\u00eda-Vilet","year":"2007","journal-title":"Am J Physiol Renal Physiol."},{"issue":"8","key":"B37-20250227","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/ndt\/gfs014","article-title":"Recovery from ischemic acute kidney injury by spironolactone administration","volume":"27","author":"S\u00e1nchez-Pozos","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B38-20250227","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11906-010-0175-6","article-title":"The kidneys and aldosterone\/mineralocorticoid receptor system in salt-sensitive hypertension","volume":"13","author":"Shibata","year":"2011","journal-title":"Curr Hypertens Rep."},{"issue":"1","key":"B39-20250227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000358758","article-title":"Local mineralocorticoid receptor activation and the role of Rac1 in obesity-related diabetic kidney disease","volume":"126","author":"Yoshida","year":"2014","journal-title":"Nephron Exp Nephrol."},{"issue":"5","key":"B40-20250227","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Aldosterone, mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B41-20250227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41440-018-0158-6","article-title":"Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease","volume":"42","author":"Nishiyama","year":"2019","journal-title":"Hypertens Res."},{"issue":"8","key":"B42-20250227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol."},{"issue":"14","key":"B43-20250227","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med."},{"key":"B44-20250227","first-page":"e005922","article-title":"Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data","volume":"12","author":"Beldhuis","year":"2019","journal-title":"Circ Heart Fail."},{"issue":"8","key":"B45-20250227","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/01.ASN.0000079785.13922.F6","article-title":"Recent advances in the pathophysiology of ischemic acute renal failure","volume":"14","author":"Bonventre","year":"2003","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B46-20250227","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1152\/ajprenal.00042.2003","article-title":"Injury of the renal microvascular endothelium alters barrier function after ischemia","volume":"285","author":"Sutton","year":"2003","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B47-20250227","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0002-9440(10)63586-9","article-title":"Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1 alpha","volume":"163","author":"Yuan","year":"2003","journal-title":"Am J Pathol."},{"issue":"4","key":"B48-20250227","doi-asserted-by":"crossref","first-page":"F928","DOI":"10.1152\/ajprenal.00596.2007","article-title":"Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor","volume":"294","author":"Basile","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B49-20250227","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/j.1523-1755.2004.66004.x","article-title":"AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction","volume":"66","author":"Fukami","year":"2004","journal-title":"Kidney Int."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:23Z","timestamp":1786478603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000665","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"2024-03-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}